GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medixall Group MDXL · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 4 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Medixall Group

Its shares trade under the ticker MDXL. It has been listed since 16 January 2003. In the fiscal year to 31 December 2024, it reported revenue of $309,422 and a net loss of $4.6m. At that date it held total assets of $201,103 and shareholders' equity of −$6.5m.

MediXall Group, Inc. is a technology company, which engages in the development of a healthcare marketplace platform. The company is headquartered in Fort Lauderdale, Florida. The company went IPO on 2003-01-16. The Company’s MediXaid platform (the MediXaid Platform) has developed a region by region medical services and products e-Marketplace. The company allows purchasers of products and services, including consumers, insurance companies, self-insured employers and at-risk providers, such as accountable care organizations and others to solicit bids from vendors including diagnostic companies and product providers. The company’s medical/healthcare regional e-marketplace allows patients to solicit for the magnetic resonance imaging (MRI) services and all other services and products within a given radius of their location. The MediXaid platform provides a range of services including reversed bidding for the product or service and a variety of conditions that can be selected by patients such as location, delivery time and insurance network affiliations.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Technology
Listed since
16 Jan 2003
Employees
19

Leadership

Pay as last reported

  • Mr. Travis JacksonChief Executive Officer, Treasurer, since 2020$205,000
  • Mr. Robert HoodChief Operating Officer, Company Secretary, Director, since 2023$91,000
  • Dr. Ann HawkinsChief Innovation & Marketing Officer$91,000
  • Ms. Susan PoniatowskiDirector
  • Mr. Gene ShvedovDirector
  • Mr. Garth WalkerDirector
  • Mr. Noel Guillama- AlvarezIndependent Director, since 2016
  • Mr. Scott PowellIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Medixall Group Inc has several strengths that contribute to its success:

Weaknesses

  • Despite its strengths, Medixall Group Inc also faces several weaknesses:

Opportunities

  • There are several opportunities that Medixall Group Inc can capitalize on:

Threats

  • Medixall Group Inc must also consider the following threats:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.